NO20023149L - Fenylpiperazinylderivater - Google Patents

Fenylpiperazinylderivater

Info

Publication number
NO20023149L
NO20023149L NO20023149A NO20023149A NO20023149L NO 20023149 L NO20023149 L NO 20023149L NO 20023149 A NO20023149 A NO 20023149A NO 20023149 A NO20023149 A NO 20023149A NO 20023149 L NO20023149 L NO 20023149L
Authority
NO
Norway
Prior art keywords
phenylpiperazinyl
Prior art date
Application number
NO20023149A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023149D0 (no
Inventor
Thomas Ruhland
Jan Kehler
Kim Andersen
Benny Bang-Andersen
Mario Rottlaender
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20023149D0 publication Critical patent/NO20023149D0/no
Publication of NO20023149L publication Critical patent/NO20023149L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO20023149A 1999-12-30 2002-06-28 Fenylpiperazinylderivater NO20023149L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901886 1999-12-30
PCT/DK2000/000720 WO2001049677A1 (en) 1999-12-30 2000-12-20 Phenylpiperazinyl derivatives

Publications (2)

Publication Number Publication Date
NO20023149D0 NO20023149D0 (no) 2002-06-28
NO20023149L true NO20023149L (no) 2002-06-28

Family

ID=8108810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023149A NO20023149L (no) 1999-12-30 2002-06-28 Fenylpiperazinylderivater

Country Status (24)

Country Link
US (1) US20030083336A1 (de)
EP (1) EP1246815B1 (de)
JP (1) JP2003519223A (de)
KR (1) KR20020067589A (de)
CN (1) CN1437596A (de)
AR (1) AR029217A1 (de)
AT (1) ATE261958T1 (de)
AU (1) AU2152001A (de)
BG (1) BG106961A (de)
BR (1) BR0016951A (de)
CA (1) CA2395867A1 (de)
DE (1) DE60009154D1 (de)
EA (1) EA200200731A1 (de)
HU (1) HUP0203645A3 (de)
IL (1) IL150337A0 (de)
IS (1) IS6431A (de)
MX (1) MXPA02006499A (de)
NO (1) NO20023149L (de)
NZ (1) NZ519692A (de)
PL (1) PL355540A1 (de)
SK (1) SK11062002A3 (de)
TR (1) TR200201684T2 (de)
WO (1) WO2001049677A1 (de)
ZA (1) ZA200204970B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040002488A1 (en) * 2002-05-29 2004-01-01 Cowart Marlon D. Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
SI1599468T1 (sl) * 2003-01-14 2008-02-29 Arena Pharm Inc 1,2,3-trisubstituirani arilni in heteroarilni derivati kot modulatorji metabolizma ter profilaksa in zdravljenje motenj v zvezi z njim, kot diabetesain hiperglikemije
RS20050532A (sr) * 2003-01-14 2007-12-31 Arena Pharmaceuticals Inc., Derivati 1,2,3-trisupstituisanog arila i heteroarila kao modulatori metabolizma za profilaksu i tretman poremećaja povezanih sa njim, kao što su dijebetes i hiperglikemija
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
EP1701940B1 (de) * 2003-12-23 2008-05-28 H.Lundbeck A/S 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
NZ555491A (en) * 2005-01-03 2010-01-29 Univ Siena Aryl piperazine derivatives for the treatment of neuropsychiatric disorders
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
KR100868353B1 (ko) * 2007-03-08 2008-11-12 한국화학연구원 도파민 d4 수용체 길항제인 신규 피페라지닐프로필피라졸유도체, 이의 제조방법 및 이를 포함하는 약학적 조성물
CN103221410B (zh) 2010-09-22 2017-09-15 艾尼纳制药公司 Gpr119受体调节剂和对与其相关的障碍的治疗
EP3083589B1 (de) 2013-12-20 2019-12-18 Sunshine Lake Pharma Co., Ltd. Substituierte piperazinverbindungen und verfahren zur verwendung davon
WO2015169180A1 (en) * 2014-05-04 2015-11-12 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods and use thereof
CN105085491B (zh) * 2014-05-05 2019-06-25 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
GB201416352D0 (en) 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
GB201416351D0 (en) 2014-09-16 2014-10-29 Shire Internat Gmbh Heterocyclic derivatives
CN105732591B (zh) * 2014-12-31 2019-10-25 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
CA3002540C (en) 2015-01-06 2023-11-07 Arena Pharmaceuticals, Inc. Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
JP6838744B2 (ja) 2015-06-22 2021-03-03 アリーナ ファーマシューティカルズ, インコーポレイテッド S1P1レセプター関連障害における使用のための(R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸(化合物1)の結晶性L−アルギニン塩
WO2017012579A1 (zh) * 2015-07-23 2017-01-26 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
CN106795143B (zh) * 2015-08-13 2019-05-24 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
CN110520124A (zh) 2017-02-16 2019-11-29 艾尼纳制药公司 用于治疗原发性胆汁性胆管炎的化合物和方法
JP7397011B2 (ja) 2018-06-06 2023-12-12 アリーナ ファーマシューティカルズ, インコーポレイテッド S1p1受容体に関連する状態を治療する方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
GB9305623D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
GB9306578D0 (en) * 1993-03-30 1993-05-26 Merck Sharp & Dohme Therapeutic agents
AU6435594A (en) * 1993-04-15 1994-11-08 Merck Sharp & Dohme Limited Indole derivatives as dopamine d4 antagonists
EP0757686A1 (de) * 1994-04-28 1997-02-12 MERCK SHARP & DOHME LTD. Benzofuranderivate als d4 rezeptor antagonisten
EP0775118B1 (de) * 1994-08-05 2003-06-04 Pfizer Inc. Benzimidazolderivate mit dopaminerger wirkung
USH2007H1 (en) * 1996-01-19 2001-12-04 Fmc Corporation Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines

Also Published As

Publication number Publication date
IS6431A (is) 2002-06-19
HUP0203645A3 (en) 2004-01-28
US20030083336A1 (en) 2003-05-01
NO20023149D0 (no) 2002-06-28
HUP0203645A2 (hu) 2003-02-28
MXPA02006499A (es) 2002-11-29
EP1246815A1 (de) 2002-10-09
ATE261958T1 (de) 2004-04-15
AR029217A1 (es) 2003-06-18
BG106961A (en) 2003-04-30
EA200200731A1 (ru) 2002-12-26
ZA200204970B (en) 2004-01-26
EP1246815B1 (de) 2004-03-17
JP2003519223A (ja) 2003-06-17
KR20020067589A (ko) 2002-08-22
IL150337A0 (en) 2002-12-01
PL355540A1 (en) 2004-05-04
SK11062002A3 (sk) 2002-12-03
BR0016951A (pt) 2003-02-25
TR200201684T2 (tr) 2002-10-21
DE60009154D1 (de) 2004-04-22
WO2001049677A1 (en) 2001-07-12
CN1437596A (zh) 2003-08-20
CA2395867A1 (en) 2001-07-12
AU2152001A (en) 2001-07-16
NZ519692A (en) 2004-05-28

Similar Documents

Publication Publication Date Title
DE60011764D1 (de) Werkstoffsprüfung
DE69932949D1 (de) Aufszugssteuerung
DE60010160T2 (de) Albumblatt
DE60002808D1 (de) Propellerrotornabe
NO20023149D0 (no) Fenylpiperazinylderivater
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DK1190020T3 (da) Celluligninbrændstof
DE50009570D1 (de) Wechselcorrugator
DE59909346D1 (de) Zylinderkopfdichtung
DE59910286D1 (de) Kniehebel-spannvorrichtung
DE69924240D1 (de) Ladungsträgerteilchenstrahlvorrichtung
DE50012482D1 (de) Tibiamarknagel
DE60045404D1 (de) Strahlungsbildaufnahmeapparatus
DE60013238D1 (de) Klingenabstreifanordnung
DE60027395D1 (de) Befehlsschleifenspuffer
DE60020201D1 (de) Koaxialkabelherstellungsverfahren
DE50003660D1 (de) Diacylhydrazinderivate
DE60027753D1 (de) Kompositnadel
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE60012398D1 (de) Alkylformamidtenside
DE69926805D1 (de) Formblaszusammensetzung
DE60000485D1 (de) Kulturgefass
DE60037169D1 (de) Chrominanzsignalinterpolation
DK1242386T3 (da) Nitro-sulfobenzamider
ATE269311T1 (de) Benzoylpyridazine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application